References
- MurrayCJVosTLozanoRDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592197222323245608
- SchuckitMATreatment of Opioid-Use DisordersN Engl J Med2016375435736827464203
- Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working GroupDrug Misuse and Dependence: UK Guidelines on Clinical ManagementLondonDepartment of Health2017
- SordoLBarrioGBravoMJMortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesBMJ2017357j155028446428
- GowingLMfFBornemannRLeSAliROral substitution treatment of injecting opioid users for prevention of HIV infection (Review8)2011
- BuktenASkurtveitSGossopMEngagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort studyAddiction2012107239339921883606
- WrightNReimerJSomainiLAre we ready to treat hepatitis C virus in individuals with opioid use disorderEur J Gastroenterol Hepatol201729111206121428914697
- StöverHBarriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physiciansEur Addict Res2011171445420975276
- FischerGNavaF SHOutcomes of opioid-dependence treatment across Europe: identifying opportunities for improvement Editorial BoardHeroin Addict Relat Clin Probl2012143950
- BrandtLUngerAMoserLFischerGJagschROpioid maintenance treatment – a call for a Joint European Quality Care ApproachEur Addict Res2016221365126314296
- FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder Available from: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm587312.htmAccessed September 26, 2018
- CamurusTransforming treatments by long-acting medications Forward-looking statements2017 Available from: https://www.camurus.com/wp-content/uploads/2017/12/Camurus-Company-Presentation-CARNEGIE-NYC-171205.pdfAccessed September 26, 2018
- RosenthalRNGoradiaVVAdvances in the delivery of buprenorphine for opioid dependenceDrug Des Devel Ther20171124932505
- IndiviorSUBLOCADE-FDA Approves SUBLOCADETM (Buprenorphine Extended-Release), the First and Only Once-Monthly Injectable Buprenorphine Formulation to Treat Moderate to Severe Opioid Use Disorder2018 Available from: http://www.indivior.com/investor-news/fda-approves-sublocade-buprenorphine-extended-release-first-monthly-injectable-buprenorphine-formulation-treat-moderate-severe-opioid-use-disorder/Accessed September 26, 2018
- CamurusCamurus Announces European Medicines Agency Validation of CAM2038 Marketing Authorization Application for Treatment of Opioid Dependence2017 Available from: http://mb.cision.com/Main/13456/2356920/729320.pdfAccessed September 26, 2018
- LofwallMRWalshSLNunesEVWeekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trialJAMA Intern Med2018178676477329799968
- NealeJTompkinsCNEMcdonaldRStrangJImplants and depot injections for treating opioid dependence: qualitative study of people who use or have used heroinDrug Alcohol Depend20181891729857327
- FischerJJenkinsNBloorMNealeJBerneyLDrug User Involvement in Treatment DecisionsYorkJoseph Rowntree Foundation2007
- MetzVEBrandtLUngerAFischerGSubstance abuse/dependence treatment: a European perspectiveSubst Abus201435330932024766667
- Drink and Drug NewsGet connected2018 Available from: https://drinkanddrugsnews.com/wp-content/uploads/2018/03/DDN-March2018.pdfAccessed September 25, 2018
- LikertRA technique for the measurement of attitudesArch Psychol19322214055
- NHS Health Research AuthorityDo I need NHS REC approval?2018 Published. Available from: http://www.hra-decisiontools.org.uk/ethics/Accessed September 25, 2018
- JohansonGABrooksGPInitial scale development: sample size for pilot studiesEduc Psychol Meas2010703394400
- SullivanGMArtinoARAnalyzing and interpreting data from likert-type scalesJ Grad Med Educ20135454154224454995
- Public Health EnglandAdult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS)20162017174 Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/658056/Adult-statistics-from-the-national-drug-treatment-monitoring-system-2016-2017.pdfAccessed September 26, 2018